Japan Science & Technology Agency
In its 13F for Q2 2026 (holdings as of June 30, 2026, filed July 31, 2026), Japan Science & Technology Agency reported 12 stock positions worth $5.3 billion. Its top holding was Ishr Ibx Usd Hiyld CB ETF-Ui (HYG) at 17.6% of the portfolio, followed by Ishr Ibx Usd Invgd CB ETF-Ui (LQD, 17.5%) and iShares Core S&P 500 ETF (IVV, 12.0%). Compared with Q1 2026, it added to 2 and reduced 1. The biggest buy was iShares Core MSCI Emerging (IEMG, shares +36%) and the biggest sale Invesco S&P 500 Equal Weight (RSP, shares −11%).
- Most Recent 13F
- Q2 2026
- Location
- TOKYO, M0
- CIK
- 0001948391
- Portfolio Value
- $5.3B (Q2 2026)
- SEC Filing
- 0001948391-26-000004 ↗ filed Jul 31, 2026
Holdings Value
Holdings 12 stocks · $5.3B
| HYG Ishr Ibx Usd Hiyld CB ETF-Ui | 17.61% | 11,640,626 | $930.9M | Add +12.0% |
| LQD Ishr Ibx Usd Invgd CB ETF-Ui | 17.55% | 8,506,450 | $927.8M | No change |
| IVV iShares Core S&P 500 ETF | 12.01% | 847,800 | $634.9M | No change |
| RSP Invesco S&P 500 Equal Weight | 10.23% | 2,541,932 | $540.8M | Reduce -10.7% |
| USHY iShares Broad Usd High Yield | 10.03% | 14,319,906 | $530.1M | No change |
| IEMG iShares Core MSCI Emerging | 9.82% | 6,270,920 | $519.5M | Add +35.7% |
| JNK SS SPDR BB High Yield Bond | 5.29% | 2,900,000 | $279.5M | No change |
| EMB iShares JP Morgan Usd Emergi | 4.56% | 2,500,000 | $241.1M | No change |
| QQQ Invesco QQQ Trust Series 1 | 4.44% | 319,081 | $235.0M | No change |
| SHYG iShares 0-5 YR HY Corp. Bond | 3.57% | 4,450,000 | $188.7M | No change |
| VUG Vanguard Mrngstar GR ETF-Sui | 3.43% | 2,105,718 | $181.4M | No change |
| VTV Vanguard Mrngstr Val ETF-Aui | 1.47% | 357,328 | $77.9M | No change |
Portfolio Sells Q1 2026 → Q2 2026
| RSP Invesco S&P 500 Equal Weight | Reduce -10.7% | 10.23% | −1.12 |
Portfolio Buys Q1 2026 → Q2 2026
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 12 | $5.3B | HYG, LQD, IVV, RSP, USHY |
| Q1 2026 | 12 | $4.8B | LQD, HYG, IVV, RSP, USHY |
| Q4 2025 | 12 | $5.4B | LQD, HYG, IVV, RSP, USHY |
| Q3 2025 | 13 | $5.6B | LQD, HYG, IVV, RSP, USHY |
| Q2 2025 | 13 | $6.3B | LQD, HYG, IVV, RSP, VCIT |
| Q1 2025 | 13 | $6.5B | LQD, HYG, IVV, RSP, VCIT |
| Q4 2024 | 11 | $5.8B | LQD, HYG, VCIT, VCSH, IGSB |
| Q3 2024 | 13 | $7.6B | LQD, VCSH, VCIT, HYG, IGSB |
| Q2 2024 | 12 | $7.2B | LQD, VCSH, VCIT, HYG, IGSB |
| Q1 2024 | 12 | $8.1B | VCSH, LQD, VCIT, HYG, IGSB |